Analyst Expectations for Vaccitech's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Vaccitech (NASDAQ:VACC) received 4 bullish and 1 somewhat bullish analyst ratings, with an average price target of $16.0, compared to its current price of $2.445. The average price target has decreased by 11.11% from the previous $18.00.
June 13, 2023 | 3:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vaccitech (NASDAQ:VACC) has received positive analyst ratings, with an average price target of $16.0, indicating potential upside from its current price of $2.445.
The majority of analyst ratings for Vaccitech are bullish or somewhat bullish, indicating a positive outlook for the stock. The average price target of $16.0 suggests a significant potential upside from the current price of $2.445. This information is important for investors as it shows that analysts have a positive view on the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100